Business & Finance
Laprophan Raises $223 Million in Africa’s Largest Pharma IPO
Key Points
Laprophan Raises $223 Million in Africa’s Largest Pharma IPO Laprophan raised 2.22 billion dirhams ($223 million) in an initial public offering on the Casablanca stock exchange, the largest flotation by an African pharmaceutical company. The Moroccan firm sold 6.52 million existing and new shares at 341 dirhams each, valuing it at about 5.9 billion dirhams. The offering was six times oversubscribed, said Bachir Tazi, executive director at CFG Bank Capital Markets, the IPO’s lead manager.
Laprophan Raises $223 Million in Africa’s Largest Pharma IPO
Laprophan raised 2.22 billion dirhams ($223 million) in an initial public offering on the Casablanca stock exchange, the largest flotation by an African pharmaceutical company.
The Moroccan firm sold 6.52 million existing and new shares at 341 dirhams each, valuing it at about 5.9 billion dirhams. The offering was six times oversubscribed, said Bachir Tazi, executive director at CFG Bank Capital Markets, the IPO’s lead manager.